Inventor
CHRISTOPHER JOHN ANDREW
GB23 patents
⚠️ This page may combine multiple inventors who share the name “CHRISTOPHER JOHN ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HEPTARES THERAPEUTICS LTD
19 patentsUS9676745B2Jun 13, 2017
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
HEPTARES THERAPEUTICS LTD10 citations92
US11584732B2Feb 21, 2023
Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
HEPTARES THERAPEUTICS LTD4 citations85
US10981889B2Apr 20, 2021
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
HEPTARES THERAPEUTICS LTD5 citations84
US10584111B2Mar 10, 2020
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
HEPTARES THERAPEUTICS LTD7 citations84
US10246432B2Apr 2, 2019
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
HEPTARES THERAPEUTICS LTD9 citations84
US9925178B2Mar 27, 2018
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD4 citations83
US9808457B2Nov 7, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD6 citations83
US9688660B2Jun 27, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD5 citations83
US11680053B2Jun 20, 2023
Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
HEPTARES THERAPEUTICS LTD2 citations73
US10888561B2Jan 12, 2021
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10316028B2Jun 11, 2019
Orexin receptor antagonists
HEPTARES THERAPEUTICS LTD1 citations72
US10300056B2May 28, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10259812B2Apr 16, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10166226B2Jan 1, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD3 citations72
US9850237B2Dec 26, 2017
Orexin receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US9802935B2Oct 31, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD4 citations72
US9555044B2Jan 31, 2017
Orexin receptor antagonists
HEPTARES THERAPEUTICS LTD3 citations72
US9249160B2Feb 2, 2016
Orexin receptor antagonists
HEPTARES THERAPEUTICS LTD3 citations72
US12240825B2Mar 4, 2025
Oxexin 1 receptor antagonists
HEPTARES THERAPEUTICS LTD0 citations60
NXERA PHARMA UK LTD
4 patentsUS12415795B2Sep 16, 2025
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
NXERA PHARMA UK LTD0 citations62
US12178813B2Dec 31, 2024
CGRP receptor antagonists
NXERA PHARMA UK LTD0 citations61
US12344621B2Jul 1, 2025
CGRP antagonist compounds
NXERA PHARMA UK LTD0 citations60
US12331029B2Jun 17, 2025
Orexin 1 receptor antagonists
NXERA PHARMA UK LTD0 citations49